search
Back to results

Taste Properties of HIV Inhibitor

Primary Purpose

HIV Infections

Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
BMS-955176
Sponsored by
ViiV Healthcare
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for HIV Infections

Eligibility Criteria

25 Years - 80 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com

Inclusion Criteria:

  • Men and women of non-childbearing potential professional sensory panelists
  • Aged between 25 and 80 years

Exclusion Criteria:

  • History of relevant drug or food allergies, cardiovascular or Central nervous system (CNS) disease, clinically significant pathology, history of mental illness
  • Positive HIV test

Sites / Locations

  • GSK Investigational Site

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

BMS-955176

Arm Description

BMS-955176 specified dose on specified days

Outcomes

Primary Outcome Measures

Taste properties of HIV Inhibitor will be measured using the Flavor Profile of the Flavor Leadership Criteria

Secondary Outcome Measures

Full Information

First Posted
November 17, 2015
Last Updated
April 13, 2018
Sponsor
ViiV Healthcare
Collaborators
Senopsys, LLC
search

1. Study Identification

Unique Protocol Identification Number
NCT02608918
Brief Title
Taste Properties of HIV Inhibitor
Official Title
An Open-Label Taste Assessment of BMS-955176 in Healthy Subjects
Study Type
Interventional

2. Study Status

Record Verification Date
April 2018
Overall Recruitment Status
Completed
Study Start Date
January 5, 2016 (Actual)
Primary Completion Date
May 24, 2016 (Actual)
Study Completion Date
May 24, 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
ViiV Healthcare
Collaborators
Senopsys, LLC

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of the study is to assess the taste properties of HIV inhibitor

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV Infections

7. Study Design

Primary Purpose
Other
Study Phase
Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
8 (Actual)

8. Arms, Groups, and Interventions

Arm Title
BMS-955176
Arm Type
Experimental
Arm Description
BMS-955176 specified dose on specified days
Intervention Type
Drug
Intervention Name(s)
BMS-955176
Other Intervention Name(s)
HIV Maturation Inhibitor
Primary Outcome Measure Information:
Title
Taste properties of HIV Inhibitor will be measured using the Flavor Profile of the Flavor Leadership Criteria
Time Frame
Up to 2 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: Men and women of non-childbearing potential professional sensory panelists Aged between 25 and 80 years Exclusion Criteria: History of relevant drug or food allergies, cardiovascular or Central nervous system (CNS) disease, clinically significant pathology, history of mental illness Positive HIV test
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Viiv Clinical Trials
Organizational Affiliation
ViiV Healthcare
Official's Role
Study Director
Facility Information:
Facility Name
GSK Investigational Site
City
Woburn
State/Province
Massachusetts
ZIP/Postal Code
01801
Country
United States

12. IPD Sharing Statement

Links:
URL
http://www.bms.com/studyconnect/Pages/home.aspx
Description
BMS clinical trial educational resource

Learn more about this trial

Taste Properties of HIV Inhibitor

We'll reach out to this number within 24 hrs